POP-OUT | CLOSE
 
Crystal Structure of HIV-1 Neutralizing Antibody CH04
Sequence Clustering and Redundancy Reduction Results
3TCL
Cluster # 3 Members. Sequence cutoff: 70% Cluster size: 1297 sequences | showing only first 1000 cluster members
Rank   PDB id Entity id Chains Description Details Taxonomy EC Number
Select for download / view details OR: Select two chains for comparison
  Download      Details  
1 4NZU 1 L 13PL heavy chain Fab 9606  
2 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
3 1MEX 1 L Fab 29G12 light chain 10090  
4 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090  
5 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090  
6 2XZC 2 L FAB A.17 LIGHT CHAIN 9606  
7 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090  
8 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090  
9 1RUK 1 L immunoglobulin igg2a, light chain fab 10090  
10 2VXV 2 L HUMAN IGG ABT-325 9606  
11 2VXT 3 L MURINE IGG 125-2H 10090  
12 1RUM 1 L immunoglobulin igg2a, light chain fab 10090  
13 2XZA 2 L FAB A.17 LIGHT CHAIN 9606  
14 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
15 3T65 2 A S25-2 FAB (IGG1K) light chain 10090  
16 4JG1 1 L Fab light chain 9606  
17 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606  
18 3IFL 1 L 12A11 FAB antibody light chain 10090  
19 3PP4 2 L GA101 Fab light chain 10090  
20 3KDM 1 A, L Immunoglobulin light chain 9606  
21 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
22 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
23 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090  
24 4HS6 2 A, L MRCT10.v362 Fab light chain 9606  
25 3IFN 2 L 12A11 FAB antibody light chain 10090  
26 3NPS 3 C S4 FAB LIGHT CHAIN 9606  
27 1RUR 1 L immunoglobulin 13G5, light chain fab 10090  
28 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090  
29 3NTC 1 L Fab light chain 10090  
30 4NWU 2 L APE1551 Ab Fab light chain 9606  
31 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
32 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090  
33 4NZR 2 L PGT135 light chain Fab 9606  
34 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090  
35 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090  
36 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606  
37 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
38 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
39 3QQ9 1 C, L 101F LIGHT CHAIN 10090  
40 3OZ9 1 L Fab NC-1 kappa light chain 10090  
41 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606  
42 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606  
43 3G5Y 1 A 175 light chain 10090  
44 4N8C 2 L, M Light chain of monoclonal antibody 10090  
45 4HGW 1 A Antibody Fab fragment, light chain 10090  
46 1NLB 1 L antibody 19D9D6 light chain 10090  
47 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
48 3VFG 1 L 3F8 Light Chain 10090  
49 3QRG 1 L Fab light chain 9606  
50 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090  
51 4K23 2 L anti-uPAR antibody, light chain 10090  
52 3NCJ 1 L Fab15 Mut8 light chain 9606  
53 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
54 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090  
55 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090  
56 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
57 4M61 1 A, C Fab A52 light chain 10090  
58 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
59 1UM5 1 L Antibody 21H3 L chain 10090  
60 4NWT 1 L APE1531 Ab Fab light chain 9606  
61 3WHX 2 B mAb Fab L fragment 10090  
62 3NA9 1 L Fab15 light chain 9606  
63 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
64 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
65 4LRI 1 A, B MSL-109 Light Chain 9606  
66 4JN2 1 A, L anti dabigatran Fab 10090  
67 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090  
68 4JFZ 1 L Fab light chain 9606  
69 3WIF 2 B mAb Fab L fragment 10090  
70 3MBX 1 L X836 LIGHT CHAIN 10090  
71 4HHA 1 A Fab KE5 Fab fragment KE5 9606  
72 3NAA 1 L Fab15 Mut5 light chain 9606  
73 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090  
74 4PUB 2 L DX-2930 LIGHT CHAIN 9606  
75 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
76 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
77 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090  
78 3UYR 2 L antibody Fab light chain 10090  
79 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090  
80 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090  
81 3OAZ 2 K, L Fab 2G12, light chain 9606  
82 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090  
83 1ZAN 1 L Fab AD11 Light Chain 10116  
84 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
85 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090  
86 4JG0 1 L Fab light chain 9606  
87 3EO0 1 A, C GC-1008 Fab Light Chain 10090  
88 4JHA 2 L D25 light chain 9606  
89 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
90 4DGV 2 L HCV1 Light Chain 9606  
91 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
92 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090  
93 1YNL 1 L Ig gamma light chain 10090  
94 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090  
95 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090  
96 4NUJ 1 A PGT152 light chain 9606  
97 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090  
98 1RUA 1 L immunoglobulin igg2a, light chain fab 10090  
99 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090  
100 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090  
101 4NUG 1 L PGT151 light chain 9606  
102 3IU4 2 L chP3 Fab light chain 10090  
103 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
104 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090  
105 1P7K 1 A, L antibody light chain FAB 10090  
106 3RVV 2 C 4C1 - light chain 10090  
107 3P0Y 3 L Fab DL11 light chain 9606  
108 2YPV 3 L FAB 12C1 10090  
109 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606  
110 3NAC 1 L Fab15 Mut7 light chain 9606  
111 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
112 1Q72 1 L Fab M82G2, Light chain 10090  
113 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090  
114 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090  
115 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
116 4DGY 2 L HCV1 Light Chain 9606  
117 3T77 1 A S25-2 FAB (IGG1K) light chain 10090  
118 3MXW 2 L 5E1 light chain 9606  
119 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630  
120 3EO9 1 L Efalizumab Fab fragment, light chain 9606  
121 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090  
122 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090  
123 3C6S 1 A, C, E, G Fab F22-4 light chain 10090  
124 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090  
125 4JM4 2 L PGT 135 Light Chain Fab 9606  
126 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
127 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090  
128 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
129 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606  
130 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606  
131 2FX7 1 L Fab 4E10 Light Chain 9606  
132 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606  
133 3WFH 2 B mAb Fab L fragment 10090  
134 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090  
135 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
136 3RVW 2 C 4C1 - light chain 10090  
137 3D85 1 A FAB of antibody 7G10, light chain light chain 9606  
138 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090  
139 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090  
140 4JN1 2 L anti-dabigatran Fab1, light chain 10090  
141 4G5Z 2 L canakinumab antibody fragment light chain 9606  
142 2OK0 2 L Fab ED10 light chain 10090  
143 3SOB 1 L antibody light chain 9606  
144 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090  
145 2IH3 2 B FAB Light Chain 10090  
146 4KQ3 1 L CNTO3186 light chain Fab 9606  
147 4JFX 1 A, L Fab light chain 9606  
148 3SGE 1 I, L Light Chain 10090  
149 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090  
150 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
151 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090  
152 1JGU 1 L Antibody Light Chain 10090  
153 4I77 2 L Lebrikizumab light chain Fab 9606  
154 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986  
155 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
156 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
157 4HJG 1 A Trastuzumab light chain 9606  
158 4M43 1 L Fragment antigen-binding 523-11 light chain 10090  
159 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
160 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
161 3FN0 1 L Fab Z13e1 light chain 9606  
162 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090  
163 1T2Q 1 L Fab NNA7 Heavy Chain 10090  
164 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090  
165 4MAU 1 L C2244 light chain SEE REMARK 999 10090  
166 3LEX 2 B, L 11f10 Antibody Light Chain 10090  
167 1OP3 1 K, L FAB 2G12, light chain light chain 9606  
168 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
169 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606  
170 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606  
171 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
172 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090  
173 4LKX 2 B Fab fragment light chain 9606  
174 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
175 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606  
176 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090  
177 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090  
178 2A77 1 L Immunoglobulin Light Chain 10090  
179 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090  
180 3QWO 1 B, L motavizumab light chain 10090  
181 3CVI 2 L 25-D1.16 Light chain 10090  
182 1PZ5 1 A Light chain of Fab (SYA/J6) 10090  
183 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116  
184 4IOI 1 A Trastuzumab light chain 9606  
185 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090  
186 4OKV 2 B, D light chain of 8H7 mAb 10090  
187 1JGV 1 L Antibody Light Chain 10090  
188 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090  
189 2ADF 3 L 82D6A3 IgG FAB 10090  
190 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090  
191 1UM4 1 L Antibody 21H3 L chain 10090  
192 3I75 1 A Antibody heavy chain 10090  
193 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606  
194 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
195 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090  
196 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090  
197 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090  
198 3OAY 1 K, L Fab 2G12, light chain 9606  
199 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090  
200 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090  
201 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
202 4GMT 1 L, M Fab S139/1 light chain 10090  
203 3ZKM 3 D, L FAB LIGHT CHAIN 10090  
204 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN 10090  
205 3HNS 2 L CS-35 Fab Light Chain Light Chain 10090  
206 1KEL 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
207 3TCL 2 B, L CH04 Light Chain Fab 9606  
208 3QOT 1 L B3 (IGKV4-1) light chain 9606  
209 1N0X 1 L, M IMMUNOGLOBULIN LIGHT CHAIN 9606  
210 2FAT 1 L FAB ATN-615, light chain 10090  
211 1RUL 1 L immunoglobulin igg2a, light chain fab 10090  
212 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
213 4H88 3 L POM1 FAB CHAIN L 10090  
214 1UM6 1 L antibody 21h3, L chain 10090  
215 2AK1 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
216 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
217 3HNV 2 L CS-35 Fab Light Chain Light Chain 10090  
218 3LEY 2 L 6a7 Antibody Light Chain 10090  
219 1YEI 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING DOMAIN 10090  
220 3QPQ 1 C, E, I, L C1068 light chain 10090  
221 2HFF 1 A, L CB2 Fab, light chain 9606  
222 4M7K 1 L 10H10 light chain SEE REMARK 999 10090  
223 1NDG 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-8 light chain 10090  
224 3OKD 1 A S25-39 Fab (IgG1k) light chain 10090  
225 2IPT 1 L IgG2a Fab fragment Heavy Chain 10090  
226 1SBS 2 L MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090  
227 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
228 4MA3 1 A, L C2095 light chain SEE REMARK 999 9986  
229 2FBJ 1 L IGA-KAPPA J539 FAB (LIGHT CHAIN) 10090  
230 1RUQ 1 L immunoglobulin 13G5 light chain fab 10090  
231 2HKF 1 L Immunoglobulin Light chain Fab fragment 10090  
232 1YEC 1 L IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090  
233 6FAB 1 L IGG1-KAPPA 36-71 FAB (LIGHT CHAIN) 10090  
234 3L5X 1 L H2L6 LIGHT CHAIN 9606  
235 2YMX 2 L FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090  
236 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
237 2R8S 2 L Fab light chain 10090  
238 4HKZ 1 A Trastuzumab light chain 9606  
239 1R3J 1 A Antibody Fab fragment light chain 10090  
240 1RIU 1 L Fab M82G2, Light Chain 10090  
241 3OKK 1 A S25-39 Fab (IgG1k) light chain 10090  
242 3BPC 1 A Fab, antibody fragment (IgG1k), light chain 10090  
243 3SO3 2 B A11 FAB light chain 9606  
244 3IDG 1 A 2F5 Fab light chain 9606  
245 2AJX 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
246 3RU8 3 L Antibody b12, Light Chain 9606  
247 1KN2 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
248 1KN4 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
249 3OAU 2 L Fab 2G12, light chain 9606  
250 2BRR 2 L, X MN20B9.34 ANTI-P1.4 ANTIBODY, FAB LIGHT CHAIN 10090  
251 3HZV 1 A S73-2 Fab (IgG1k) light chain 10090  
252 1NBZ 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
253 3LS5 1 L Light chain of antibody Fab fragment 10090  
254 3FO9 1 A, L Immunoglobulin IGG2A - light chain light chain of 33F12 Fab' fragment 10090  
255 1E4W 2 L TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
256 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090  
257 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
258 4HIE 1 A Fab 023.102 9606  
259 1FL3 2 B, L BLUE FLUORESCENT ANTIBODY (19G2)-LIGHT CHAIN FAB FRAGMENT 10090  
260 4LEX 1 L FAB HEAVY CHAIN 10090  
261 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606  
262 3SE9 3 L Light chain of antibody VRC-PG04 antibody light chain 9606  
263 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606  
264 3EYS 1 L If kappa light chain 10090  
265 3WE6 2 B mAb Fab L fragment 10090  
266 12E8 1 L, M IGG1-KAPPA 2E8 FAB (LIGHT CHAIN) FAB FRAGMENT 10090  
267 1A3R 1 L IGG2A 8F5 FAB (LIGHT CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090  
268 1HIL 1 A, C IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN) 10090  
269 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
270 1F58 1 L PROTEIN (IGG1 ANTIBODY 58.2 (LIGHT CHAIN)) 10090  
271 1QKZ 3 L ANTIBODY FAB 10090  
272 2G60 1 L anti-FLAG M2 Fab light chain 10090  
273 4KMT 1 L light chain O12/KAPPA Fab 9606  
274 2FR4 2 A, L antibody light chain FAB antigen-binding fragment 10090  
275 3NZH 1 L 5F6 LIGHT CHAIN 10090  
276 1RHH 1 A, C Fab X5, light chain 9606  
277 2Q76 1 A, C Fab F10.6.6 fragment Light Chain domain VL and CL 10090  
278 1TJG 1 L FAB 2F5 Light Chain 9606  
279 1YEF 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
280 1YEG 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
281 3IFO 2 B, L 10D5 FAB antibody light chain 10090  
282 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606  
283 4M7J 2 L S25-26 Fab (Igg1k) light chain 10090  
284 1UYW 2 L, N FAB ANTIBODY LIGHT CHAIN 10090  
285 2XQY 3 K, L A13-D6.3 MONOCLONAL ANTIBODY LIGHT CHAIN OF FAB FRAGMENT 10090  
286 3O6K 1 L 11H6H1 Fab' light chain 10090  
287 3C5S 1 A, C Fab F22-4 light chain 10090  
288 1RZ7 1 L Fab 48d light chain 9606  
289 1RZG 2 B, D Fab 412d heavy chain 9606  
290 1GPO 1 L, M ANTIBODY M41 FAB FRAGMENT 10090  
291 3QOS 1 A, L B3 (IGKV4-1) light chain 9606  
292 2HVK 2 B Antibody Fab light chain 10090  
293 1MJJ 1 A, L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
294 3PGF 3 L SAB Light Chain 9606  
295 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606  
296 1P2C 1 A, D light chain anti-lysozyme antibody F10.6.6 10090  
297 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
298 1ORS 1 A 33H1 Fab light chain 10090  
299 1MLB 1 A IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090  
300 2ZKH 1 L Monoclonal TN1 FAB light chain 9606  
301 3OJD 1 A Fab V2D2 Light chain 10090  
302 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
303 3ZKN 3 D, L FAB LIGHT CHAIN 10090  
304 1LO0 1 L, X If kappa light chain Fab fragment 10090  
305 35C8 1 L IGG 5C8 FAB 10090  
306 1MIE 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090  
307 4DVB 2 B, L Fab fragment of pro-uPA antibody mAb-112 10090  
308 1RFD 1 L Fab M82G2, Light Chain 10090  
309 2QQN 3 L Antibody light chain 9606  
310 3RVT 1 C Fab fragment of 4C1 antibody - light chain 10090  
311 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
312 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
313 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606  
314 3EOT 2 L FAB FRAGMENT, LIGHT CHAIN 10090  
315 4MA7 3 L POM1 light chain Fab 10090  
316 1LO2 1 L, X If kappa light chain Fab fragment 10090  
317 1UZ6 1 E, L, M, V IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
318 2D03 1 L anti-glycophorin A type N immunoglobulin light chain 10090  
319 3UJT 2 L, M Ab-52 light chain Fab fragment 10090  
320 3O6L 1 L 11H6H1 Fab' light chain 10090  
321 3E8U 2 L Fab 106.3 light chain 10090  
322 1C5B 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
323 4JZN 2 B, D, P Anti-HCV E2 Fab HC84-1 light chain 9606  
324 2CMR 3 L D5 9606  
325 3GNM 1 L JAA-F11 Fab Antibody Fragment, Light Chain 10090  
326 2FD6 2 L L chain of Fab of ATN-615 anti-uPAR antibody 10090  
327 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606  
328 1TET 1 L IGG1 TE33 FAB (LIGHT CHAIN) 10090  
329 4BZ2 3 L FAB 2D73 LIGHT CHAIN 10090  
330 2AEP 3 L FAB light chain 10090  
331 4MSW 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
332 3GRW 2 L Fab light chain 9606  
333 3LS4 1 L Light chain of antibody Fab fragment 10090  
334 1D5I 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
335 1OSP 1 L FAB 184.1 10090  
336 1F8T 1 L ANTIBODY FAB FRAGMENT (LIGHT CHAIN) 10090  
337 4LSP 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 9606  
338 2R2H 1 A Fab, antibody fragment (IgG1k), light chain 10090  
339 1DQJ 1 A ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
340 1RIV 1 L Fab M82G2, Light Chain 10090  
341 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606  
342 1Q9K 1 A S25-2 Fab (IgG1k) light chain Light Chain kappa 10090  
343 4OTX 1 L, M N203 light chain Fab 10090  
344 1K4C 2 B antibody Fab fragment light chain 10090  
345 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
346 1E4X 3 L, M TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
347 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606  
348 3CLF 1 L Fab light chain 10090  
349 4HIX 2 L Humanized 3D6 Fab light chain 10090  
350 4LKC 1 A Fab fragment of PCSK9 antibody 9606  
351 1MHH 1 A, C Fab, light chain 10090  
352 4GW5 1 A, C Fab Light Chain 10090  
353 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
354 4KZD 2 L BL3-6 Fab antibody, light chain 10090  
355 4HCR 2 L, N PF-547659 light chain 9606  
356 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606  
357 1C1E 1 L CATALYTIC ANTIBODY 1E9 (LIGHT CHAIN) FAB FRAGMENT 10090  
358 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
359 1YEK 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
360 4HIH 1 A, C Fab 023.102 9606  
361 1D6V 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
362 1YY8 1 A, C Cetuximab Fab Light chain 10090  
363 4ONG 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
364 4ETQ 2 B, L anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, light chain Fab 10090  
365 3QPX 1 L Fab C2507 light chain 10116  
366 2R0Z 1 L IgG2a Fab fragment light chain light chain 10090  
367 3DRQ 1 A 2F5 Fab' light chain 9606  
368 3NIG 4 F, L Monoclonal antibody 10E5 light chain 10090  
369 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
370 1KEM 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
371 25C8 1 L IGG 5C8 FAB 10090  
372 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606  
373 3PHQ 1 A S64-4 Fab (IgG1) light chain 10090  
374 3G5V 1 A 806 light chain 10090  
375 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
376 3D0V 1 A 2F5 Fab heavy chain 9606  
377 2C1P 1 A, L IGK-C PROTEIN 10090  
378 4O51 1 A, C, E, L QAA-2095-2 light chain 9986  
379 3S34 1 L 1121B Fab light chain 10090  
380 1GAF 1 L CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
381 2P7T 2 B FAB-B 10090  
382 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
383 4HXA 1 L 13D9 FAB LIGHT CHAIN 10090  
384 1NDM 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-26 light chain 10090  
385 2IQA 1 A, L IgG2a Fab fragment PFA2 Kappa light chain 10090  
386 1H0D 1 A ANTIBODY FAB FRAGMENT, LIGHT CHAIN HINGE REGION OBSERVED IN THE FAB FRAGMENT 9606  
387 2F5B 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
388 3MNW 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and human Fc 10090  
389 1IL1 2 B monoclonal antibody G3-519 (light chain) FAB FRAGMENT 10090  
390 1U8I 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
391 2VDR 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
392 2RCS 1 L IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090  
393 1JGL 1 L Ig kappa-chain 10090  
394 4G6J 3 L light chain of antibody binding fragment of canakinumab light chain of antibody binding fragment of canakinumab 9606  
395 2AJ3 1 A, C, E Fab m18, Light Chain 9606  
396 1SY6 1 L OKT3 Fab light chain fab fragment light chain 10090  
397 3T3P 4 F, L Monoclonal antibody 10E5 light chain 10090  
398 1EMT 1 L IGG ANTIBODY (LIGHT CHAIN) FAB FRAGMENT 10090  
399 3IDI 1 A 2F5 Fab light chain 9606  
400 1CLO 1 L A5B7 MONOCLONAL ANTIBODY ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 ANTIGEN BINDING FRAGMENT, FAB 10090  
401 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630  
402 1FE8 3 L, M, N IMMUNOGLOBULIN IGG RU5 FAB FRAGMENT LIGHT CHAIN 10090  
403 3QO0 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606  
404 4NRX 3 B, E, L m66 Light Chain 9606  
405 2Y5T 2 B CIIC1 FAB FRAGMENT LIGHT CHAIN DISULFIDE BRIDGE BETWEEN B23 AND B92, B138 AND B198 10090  
406 1L7T 1 L anti-testosterone (light chain) fab77 fragment 10090  
407 3O2D 1 L ibalizumab light chain 10090  
408 4GW1 1 A, C Fab light chain 10090  
409 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606  
410 3IJH 1 A, C Immunoglobulin light chain (IGG3) 10090  
411 1XGP 1 A antibody kappa light chain 10090  
412 2VL5 2 B, D CIIC1 ANTICOLLAGEN FAB 10090  
413 1YNK 1 L immunoglobulin kappa light chain 10090  
414 1DQD 1 L FAB HGR-2 F6 LIGHT CHAIN 10090  
415 1AJ7 1 L IMMUNOGLOBULIN 48G7 FAB (LIGHT CHAIN) VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090  
416 2R0L 1 L antibody light chain 32630  
417 4M93 1 C, L S25-26 Fab (IgG1k) light chain 10090  
418 1DN0 1 A, C IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN) FAB FRAGMENT 9606  
419 2PCP 1 A, C IMMUNOGLOBULIN COMPLEXED WITH 1-(1-PHENYLCYCLOHEXYL) PIPERIDINE (PCP, OR PHENCYCLIDINE) FAB 10090  
420 1AY1 1 L TP7 FAB FAB 10090  
421 1MH5 1 A, L IMMUNOGLOBULIN MS6-164 Fab fragment, LIGHT CHAIN 10090  
422 4MA8 3 L POM1 light chain Fab 10090  
423 4P9M 1 L 8ANC195 light chain 8ANC195 LIGHT CHAIN 9606  
424 3SGD 1 I, L Light Chain 10090  
425 3HZY 1 A S73-2 Fab (IgG1k) light chain 10090  
426 3GIZ 1 L Fab fragment of anti-CD20 antibody Ofatumumab, light chain 9606  
427 2HRP 1 L, M MONOCLONAL ANTIBODY F11.2.32 FAB FRAGMENT 10090  
428 3QNZ 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606  
429 1I8M 3 A, L ANTIBODY LIGHT CHAIN FAB 10090  
430 3NID 4 F, L Monoclonal antibody 10E5 light chain 10090  
431 3Q1S 1 L Z13e1 Fab light chain 9606  
432 1U8H 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
433 3FO2 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090  
434 1KCU 1 L PC287 IMMUNOGLOBULIN light chain 10090  
435 2CK0 1 L PROTEIN (IMMUNOGLOBULIN; LIGHT CHAIN) IGG1, KAPPA FAB FRAGMENT 10090  
436 1AXT 1 L IMMUNOGLOBULIN IGG2A FAB' FRAGMENT 33F12 10090  
437 1VPO 1 L anti-testosterone (light chain) fab77 fragment 10090  
438 1NBV 1 L IGG2B-KAPPA BV04-01 FAB (LIGHT CHAIN) 10090  
439 4IMK 2 C, D Light Chain 9606  
440 1OAK 1 L NMC-4 IGG1 THE ANTIBODY HEAVY CHAIN CONSISTS OF TWO SEGMENTS, H1 AND H2, BOTH LABELED CHAIN H IN THIS ENTRY FAB FRAGMENT, AN ANTI VON WILLEBRAND FACTOR (VWF) A1 DOMAIN 10090  
441 1XGU 1 A antibody kappa light chain 10090  
442 4JZO 2 B, E, F, H Anti-HCV E2 Fab HC84-27 light chain 9606  
443 2F5A 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
444 4OLU 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
445 3KR3 3 L antibody-Fab (light chain) 9606  
446 2HKH 1 L Immunoglobulin Light chain Fab fragment 10090  
447 1UB5 2 B, L antibody 19G2, beta chain 10090  
448 4KVC 2 L Ig kappa chain V-V region MOPC 21, Anti-colorectal carcinoma light chain 10090  
449 4OLX 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
450 2AJY 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
451 1DQM 1 L ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
452 1YEE 1 L IGG2A FAB FRAGMENT (D2.5) TRANSITION STATE ANALOGUE 10090  
453 1QBL 1 L FABE8A IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
454 2NY0 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
455 4LSQ 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 WITH N70D MUTATION 9606  
456 3ZE2 4 F, L 10E5 FAB LIGHT CHAIN 10090  
457 4LVO 2 B NIMP.M7 Fab light chain 10090  
458 3MOA 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
459 2VDO 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
460 3S35 2 L 6.64 Fab light chain 10090  
461 3HZK 1 A S73-2 Fab (IgG1k) light chain 10090  
462 3QO1 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606  
463 3OKN 1 A S25-39 Fab (IgG1k) light chain 10090  
464 2PR4 1 L nmAb 2F5 Fab' Heavy Chain 9606  
465 4D9Q 2 D, L Anti-Factor D, light chain 9606  
466 1A4J 1 A, L IMMUNOGLOBULIN, DIELS ALDER CATALYTIC ANTIBODY (LIGHT CHAIN) FAB 10090  
467 3QNY 1 A, C FAB FRAGMENT OF IMMUNOGLOBULIN A1 LIGHT CHAIN 9606  
468 4LVN 2 B NIMP.M7 Fab light chain 10090  
469 3VG0 1 L Monoclonal antibody 9F8 Fab fragment L chain 10090  
470 1BGX 2 L TP7 MAB FAB 10090  
471 1YYM 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
472 3ZDX 4 F, L 10E5 FAB, LIGHT CHAIN 10090  
473 3DGG 1 A, C FabOX108 Light Chain Fragment 9606  
474 1MJ7 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090  
475 2Z4Q 1 A anti egfr antibody fab, light chain 10090  
476 1CT8 1 A, C 7C8 FAB FRAGMENT; SHORT CHAIN 10090  
477 1FL5 1 A, L ANTIBODY GERMLINE PRECURSOR TO ANTIBODY 28B4 LIGHT CHAIN (CHAINS L AND A) 10090  
478 2VDQ 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
479 2O5Z 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
480 4OM0 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
481 1MRE 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090  
482 3AAZ 2 B, L Humanized recombinant Fab fragment of a murine; antibody 9606  
483 3WFD 1 L antibody fab fragment light chain 10090  
484 1XGQ 1 A antibody kappa light chain 10090  
485 3O2V 1 L Chimeric antibody Fab 1E9, light chain 10090  
486 3NIF 4 F, L Monoclonal antibody 10E5 light chain 10090  
487 4LSR 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 (N70D MUTATION) 9606  
488 2I5Y 2 L, Q Antibody 17B Light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
489 2CGR 1 L IGG2B-KAPPA NC6.8 FAB (LIGHT CHAIN) 10090  
490 2FX9 1 L, M Fab 4E10 Light Chain 9606  
491 4BZ1 3 L FAB 3E31 LIGHT CHAIN 10090  
492 1MRD 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090  
493 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090  
494 2NY7 3 L ANTIBODY b12, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
495 3U1S 1 L Fab PGT145 Light chain fragment antigen binding 9606  
496 1BZ7 1 A PROTEIN (ANTIBODY R24 (LIGHT CHAIN)) FAB 10090  
497 1TZG 1 L, M Fab 4E10 light chain 9606  
498 3W9D 2 B, D Antibody Fab light chain 9606  
499 2VXU 2 L, M MURINE IGG 125-2H 10090  
500 1U95 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
501 1IKF 1 L IGG1-KAPPA R45-45-11 FAB (LIGHT CHAIN) 9606  
502 4LQF 3 L Murine IgG2b A2C7 Light chain Fab domain 10090  
503 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606  
504 1NCB 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090  
505 3BN9 2 C, E E2 Fab Light Chain 9606  
506 3MNV 1 A, C ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
507 3GK8 1 L Fab 14 Light Chain 10090  
508 4HWE 2 L Fab light chain light chain 9606  
509 4AEI 3 L, M, N FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090  
510 1MRF 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090  
511 2AI0 1 L, M, N, O Immunoglobulin Light Chain kappa 10090  
512 1S5H 1 A ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
513 1IQW 1 L ANTIBODY M-HFE7A, LIGHT CHAIN FAB FRAGMENT 10090  
514 1A0Q 1 L 29G11 FAB (LIGHT CHAIN) PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL]PHOSPHONATE HAPTEN FAB 10090  
515 1U8K 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
516 1XF2 2 A, L antibody light chain Fab 10090  
517 3MCK 1 A, L C705 MONOCLONAL LIGHT CHAIN 10090  
518 1T66 1 C, L immunoglobulin light chain FAB 10090  
519 2H1P 1 L 2H1 FAB 10090  
520 1EAP 1 A IGG2B-KAPPA 17E8 FAB (LIGHT CHAIN) 10090  
521 4OCX 2 L Fab ADD056 Light Chain 10090  
522 1UWX 3 K, L ANTIBODY RESIDUES 3-214 (FAB FRAGMENT, LIGHT CHAIN) 10090  
523 3L95 1 A, L anti-NRR1 fab fragment light chain 9606  
524 3V0V 1 B, L WN1 222-5 Fab (IgG2a) light chain 10090  
525 4OGX 3 L DX-2930 LIGHT CHAIN 9606  
526 3W9E 3 B Antibody Fab light chain 9606  
527 3UTZ 1 A, D, E Metalloproteinase 10090  
528 1QBM 1 L E8B ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB FRAGMENT 10090  
529 1OM3 1 L, M FAB 2G12, light chain light chain 9606  
530 4KZE 2 L BL3-6 Fab antibody, light chain 10090  
531 3WKM 3 L, M MOUSE IGG1-KAPPA FAB (LIGHT CHAIN) 10090  
532 4HIJ 1 A, C Fab 023.102 light chain 9606  
533 1LO3 1 L, X If kappa light chain Fab fragment 10090  
534 3FO1 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090  
535 1XGR 1 A antibody kappa light chain 10090  
536 3ZDY 4 F, L 10E5 FAB LIGHT CHAIN 10090  
537 1MRC 1 L IGG2B-KAPPA JEL103 FAB (LIGHT CHAIN) 10090  
538 3IET 1 A, C Immunoglobulin light chain (IgG2a) 10090  
539 1XF3 1 A, L Fab Light chain 10090  
540 2BMK 1 A, L FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT CHAIN 10090  
541 3QCT 2 L LT3015 antibody Fab fragment, light chain 9606  
542 3EYF 1 A, C 8f9 Fab 9606  
543 3NAB 1 L Fab15 Mut6 light chain 9606  
544 3IDN 1 A 2F5 Fab light chain 9606  
545 1XGT 1 A antibody kappa light chain 10090  
546 1IGJ 1 A, C IGG2A-KAPPA 26-10 FAB (LIGHT CHAIN) 10090  
547 2Q8B 2 L 1F9 light chain 10090  
548 1RZ8 1 A, C Fab 17b light chain 9606  
549 1Q9L 2 A, C S25-2 Fab (IgG1k) light chain Fab Light chain kappa 10090  
550 4UUJ 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
551 4OLY 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
552 4FNL 2 L, M Antibody C05, Light Chain 9606  
553 2DTM 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
554 1U92 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
555 1CIC 1 A PROTEIN (IG HEAVY CHAIN V REGIONS) FAB IMMUNOGLOBULIN FRAGMENT 10090  
556 1CIC 3 C PROTEIN (IG HEAVY CHAIN V REGIONS) FAB IMMUNOGLOBULIN FRAGMENT 10090  
557 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606  
558 1C5D 1 A, L MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR FAB FRAGMENT, HEAVY CHAIN 10116  
559 1BJ1 1 J, L FAB FRAGMENT HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090  
560 1U91 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
561 2IQ9 1 L IgG2a Fab fragment PFA2 Kappa light chain 10090  
562 1F90 1 L FAB FRAGMENT OF MONOCLONAL ANTIBODY 10090  
563 3RVX 2 C 4C1 - light chain 10090  
564 2FX8 1 L, M, N, O Fab 4E10 Light Chain 9606  
565 1NGY 1 A Mature Metal Chelatase Catalytic Antibody, Light chain Fab fragment 10090  
566 4G6A 3 D, L AP33 Light chain antibody Fab 9606  
567 1M7D 1 A light chain of the monoclonal antibody Fab SYA/J6 10090  
568 3IDX 3 L Fab b13 light chain 9606  
569 1U8Q 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
570 1EHL 2 L ANTI-(6-4) PHOTOPRODUCT ANTIBODY 64M-2 FAB (LIGHT CHAIN) 10090  
571 2VDL 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
572 3IDJ 1 A 2F5 Fab light chain 9606  
573 3IDM 1 A 2F5 Fab light chain 9606  
574 1U8J 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
575 1ZLV 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
576 4K94 1 L Fab19 heavy chain 9606  
577 1K4D 2 B antibody Fab fragment light chain 10090  
578 1IGC 1 L IGG1-KAPPA MOPC21 FAB (LIGHT CHAIN) 10090  
579 1ZLS 1 L FAB 2G12, light chain FAB, Light Chain 9606  
580 4L5F 3 L Light chain of E106 antibody (kappa) VL anD CL domains 10090  
581 1RIH 1 L light chain of antibody 14F7 Fab 10090  
582 1MLC 1 A, C IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090  
583 1FDL 1 L IGG1-KAPPA D1.3 FAB (LIGHT CHAIN) 10090  
584 3V6F 2 B, D, F, L Fab e6 Light Chain 10090  
585 2W65 2 B, D ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
586 1I7Z 1 A, C CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION THE CHIMERA CONSISTS OF RESIDUES 1-108 OF MOUSE PORTION AND 109-214 OF HUMAN PORTION OF IG KAPPA CHAIN. 10090  
587 4KI5 2 D MURINE MONOCLONAL 3E6 FAB LIGHT CHAIN 10090  
588 4KI5 4 F MURINE MONOCLONAL G99 FAB LIGHT CHAIN 10090  
589 3D0L 1 A 2F5 heavy chain 9606  
590 4JPK 2 L Putative VRC01 germline precursor Fab light chain 9606  
591 3QG6 1 A, L AP4-24H11 Light Chain 10090  
592 4NX3 3 A Mouse Fab Light Chain 10090  
593 2B2X 3 L, M Antibody AQC2 Fab AQC2 Fab Light Chain 10090  
594 1XF4 1 A, L Fab light chain 10090  
595 2W0F 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
596 2HFE 2 B FAB Light Chain 10090  
597 4HT1 3 L chimeric antibody Fab 9986  
598 2Q8A 2 L 1F9 light chain 10090  
599 4U0R 3 C Monoclonal antibody 9AD4 light chain 9986  
600 2JK5 2 B ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
601 2H8P 2 B FAB light chain 10090  
602 1YEH 1 L FAB FRAGMENT IG GAMMA-2A CHAIN C REGION (D2.3) 10090  
603 3WFE 1 L antibody fab fragment light chain 10090  
604 3FCT 1 A, C PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY) CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606  
605 2J4W 3 L FAB FRAGMENT OF MONOCLONAL ANTIBODY F8.12.19 MONOCLONAL ANTIBODY ISOTYPE IS IGG1, KAPPA 10090  
606 15C8 1 L IGG 5C8 FAB (LIGHT CHAIN) FAB 10090  
607 1KEG 2 L Anti-(6-4) photoproduct antibody 64M-2 Fab (light chain) 10090  
608 1NCA 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090  
609 2P8L 1 A nmAb 2F5, light chain 9606  
610 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN FAB FRAGMENT 10090  
611 1RU9 1 L immunoglobulin igg2a, light chain fab 10090  
612 1CK0 1 L PROTEIN (IGG1-KAPPA ANTIBODY 131 (LIGHT CHAIN)) FAB 10090  
613 1UB6 2 B, L antibody 19G2, beta chain 10090  
614 4HXB 1 L 6B9 FAB LIGHT CHAIN 10090  
615 3WFC 1 L antibody fab fragment light chain 10090  
616 3R06 1 A, C, E, L anti-mouse CD3epsilon antibody 2C11 Fab light chain 10032  
617 1WC7 1 A, L FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT CHAIN 10090  
618 3G5X 1 A, C 806 light chain 10090  
619 2Z92 2 B Anti-ciguatoxin antibody 10C9 Fab light chain 10090  
620 1A4K 1 A, L ANTIBODY FAB FAB 10090  
621 1CF8 1 L PROTEIN (CATALYTIC ANTIBODY 19A4 (LIGHT CHAIN)) FAB, VARIABLE REGION 10090  
622 3T3M 4 F, L Monoclonal antibody 10E5 light chain 10090  
623 1KC5 1 L PC287 Immunoglobulin light chain 10090  
624 4I2X 1 A, C FabOX117 light chain 9606  
625 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090  
626 4K2U 3 L, M Antibody Light Chain 10090  
627 3O6M 1 L 11H6H1 Fab' light chain 10090  
628 2I60 2 L, Q ANTIBODY 17B LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
629 1A6T 1 A, C IGG1 FAB1-IA FAB (LIGHT CHAIN) FAB FRAGMENT 10090  
630 2G5B 1 A, C, E, G 6A7 Fab Light Chain 10090  
631 4EDW 2 L tanezumab Fab light chain 9606  
632 2DDQ 2 L R310 antibody light chain 10090  
633 4MA1 2 C, F, L S25-26 Fab (IgG1k) light chain 10090  
634 1UCB 1 L CHIMERIC HUMAN/MOUSE IGG FAB FRAGMENT BR96 MOUSE VH AND VL DOMAINS, HUMAN CL KAPPA AND CH1 IGG1 DOMAINS 9606  
635 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606  
636 2NY5 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
637 4NM4 1 L, M Antibody CR8043, Light Chain 9606  
638 4LST 3 L LIGHT CHAIN OF ANTIBODY VRC01 9606  
639 2VDP 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
640 3U7Y 3 L NIH45-46 light chain, Ig kappa chain C region 9606  
641 1U8M 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
642 1R3I 1 L Antibody Fab fragment light chain 10090  
643 4D9R 2 D, L Fab light chain 9606  
644 4F3F 1 A MORAb-009 Fab light chain 10090  
645 3U7W 2 L Light chain, Ig kappa chain C region 9606  
646 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606  
647 4G7V 2 L fragment antibody light chain 9606  
648 2ADG 1 A Q425 Fab Light chain 10090  
649 4HDI 1 A, L Kappa light chain variable region, Anti-colorectal carcinoma light chain 10090  
650 2AJZ 1 A, L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
651 1I9J 1 L RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB FRAGMENT LIGHT CHAIN 10090  
652 4HFW 1 A, L 6-26 Fab Light chain 9606  
653 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
654 1Y0L 1 A, C, E, L Catalytic Antibody Fab 34E4 Light chain THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE. 10090  
655 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606  
656 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090  
657 4KQ4 1 L CNTO7357 light chain Fab (mouse variable domain, human constant domain) 10090  
658 3INU 2 L, N KZ52 antibody fragment light chain 9606  
659 3OKO 2 A S25-39 Fab (IgG1k) heavy chain 10090  
660 1R3L 1 A Antibody Fab fragment light chain 10090  
661 3DIF 1 A, C FabOX117 Light Chain Fragment 9606  
662 4NCC 1 1, L Fab fragment light 10090  
663 4LBE 2 B Fab heavy chain 10090  
664 4PB9 2 L Ab64 light chain 10090  
665 3LEV 2 L 2F5 ANTIBODY LIGHT CHAIN 9606  
666 2VQ1 1 A, E IGKV1-117 PROTEIN ANTIGEN BINDING FRAGMENT 10090  
667 4OLV 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
668 1RJL 1 A Fab H6831 L-chain 10090  
669 1BQL 1 L HYHEL-5 FAB (LIGHT CHAIN) 10090  
670 2ORB 1 L, M Monoclonal anti-c-myc antibody 9E10 light chain of antigen binding fragment, Fab 10090  
671 1IGI 1 L IGG2A-KAPPA 26-10 FAB (LIGHT CHAIN) 10090  
672 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606  
673 4G3Y 1 L infliximab Fab L 9606  
674 1MAM 1 L IGG2B-KAPPA YST9.1 FAB (LIGHT CHAIN) 10090  
675 2VDK 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
676 1PLG 1 L IGG2A=KAPPA= FAB FRAGMENT THAT BINDS POLYSIALIC ACID 10090  
677 2EH7 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090  
678 1BFO 1 A, C, E, G CAMPATH-1G ANTIBODY FAB FRAGMENT 10117  
679 1RZJ 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606  
680 3OKE 1 A S25-39 Fab (IgG1k) light chain 10090  
681 4HII 1 A, C Fab 023.102 light chain 9606  
682 1K6Q 1 L immunoglobulin Fab D3, light chain Fab fragment 10090  
683 2EH8 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090  
684 1KCS 1 L PC282 IMMUNOGLOBULIN light chain 10090  
685 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606  
686 4DN3 1 L CNTO888 LIGHT CHAIN 9606  
687 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606  
688 4LSS 3 L LIGHT CHAIN OF ANTIBODY VRC01 with N72T mutation 9606  
689 4EDX 2 A, L light chain of FAB of murine anti-NGF 10090  
690 1MPA 1 L MN12H2 IGG2A-KAPPA FAB FRAGMENT 10090  
691 3IF1 1 A, C Immunoglobulin light chain (IgG2a) 10090  
692 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606  
693 4JFY 1 A, L Fab light chain 9606  
694 3MOB 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
695 3EYV 1 A, L hu3S193 Fab, light chain 10090  
696 2JEL 1 L JEL42 FAB FRAGMENT 10090  
697 1GC1 3 L ANTIBODY 17B MONOCLONAL ANTIBODY 17B BINDS TO A CD4-INDUCED SITE ON GP120 ANTIGEN-BINDING FRAGMENT, FAB 9606  
698 3STL 2 B antibody Fab fragment light chain 10090  
699 1FOR 1 L IGG2A-KAPPA 17-IA FAB (LIGHT CHAIN) 10090  
700 1HKL 1 L 48G7 FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
701 3EYU 1 L If kappa light chain 10090  
702 3PP3 2 K, L GA101 Fab light chain 10090  
703 1MIM 1 L CHIMERIC SDZ CHI621 MURINE ANTI-CD25 MONOCLONAL ANTIBODY, RFT5, CHIMERIZED WITH THE CONSTANT REGIONS OF HUMAN 1GG1 HEAVY AND KAPPA LIGHT CHAINS IGG FAB 9606  
704 2R0W 1 L IgG2a Fab fragment light chain light chain 10090  
705 3CFD 1 A, L PURPLE-FLUORESCENT ANTIBODY EP2-25C10-KAPPA LIGHT CHAIN FAB 10090  
706 1NCC 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090  
707 1NCD 2 L IGG2A-KAPPA NC41 FAB (LIGHT CHAIN) 10090  
708 3BDY 2 L Fab Fragment -Light Chain 9606  
709 1IFH 1 L IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN) 10090  
710 2UYL 1 A, M, V, X MONOCLONAL ANTIBODY F-22-30 10090  
711 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606  
712 1G9M 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
713 1EJO 1 L IGG2A MONOCLONAL ANTIBODY (LIGHT CHAIN) FAB FRAGMENT 10090  
714 4J8R 1 A, C Light chain of POM2 Fab unp residues 67-82 10090  
715 3CMO 1 L, X Fab light chain 10090  
716 3K2U 4 L Antibody, Fab fragment, Light Chain 9606  
717 4BH8 1 A ANTI-ARS MURINE GERMLINE MONOCLONAL ANTIBODY 36-65 ANTIGEN BINDING FRAGMENT 10090  
718 4PB0 2 L Ab53 light chain 10090  
719 3RVU 1 C 4C1 Fab - light chain 10090  
720 1CU4 1 L FAB LIGHT CHAIN FAB ANTIBODY 3F4, LIGHT CHAIN 10090  
721 1U8N 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
722 4HWB 3 L Fab light chain 9606  
723 1CBV 2 L PROTEIN (FAB (BV04-01) AUTOANTIBODY-LIGHT CHAIN) 10090  
724 1AXS 1 A, L OXY-COPE CATALYTIC ANTIBODY CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606  
725 3OKM 1 A S25-39 Fab (IgG1k) light chain 10090  
726 1U93 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
727 2IH1 2 B FAB Light Chain 10090  
728 1XF5 2 A, C Monoclonal antibody 19D9D6 Light chain 10090  
729 3O2W 1 L Chimeric antibody Fab 1E9, light chain 10090  
730 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090  
731 1FGN 1 L IMMUNOGLOBULIN FAB 5G9 A MONOCLONAL FAB AGAINST HUMAN TISSUE FACTOR LIGHT CHAIN RESIDUES 1 - 214, HEAVY CHAIN RESIDUES 1 - 214 10090  
732 2HFG 1 L CB3s Fab light chain (kappa) 9606  
733 3CFJ 1 A, C, E, L CATALYTIC ANTIBODY FAB 34E4 LIGHT CHAIN FUSION PROTEIN OF THE VARIABLE DOMAIN (AUTHOR RESIDUES 1-105) AND THE CONSTANT DOMAIN (UNP RESIDUES 131-239) 10090  
734 2MPA 1 L PROTEIN (MN12H2 IGG2A-KAPPA) FAB FRAGMENT 10090  
735 3GKW 2 L Light chain of the antibody Nimotuzumab 9606  
736 2A1W 1 L, M immunoglobulin light chain kappa Fab fragment, light chain 10090  
737 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606  
738 3O0R 1 L antibody fab fragment light chain 10090  
739 4JQI 3 L Fab30 light chain 10090  
740 1FAI 1 L IGG2B-KAPPA R19.9 FAB (LIGHT CHAIN) 10090  
741 3SKJ 1 L, M Antibody, light chain 9606  
742 3U30 2 B, E Light chain Fab 9606  
743 3QCV 2 L, M LT3015 antibody Fab fragment, light chain 9606  
744 1M7I 1 A light chain of the monoclonal antibody Fab SYA/J6 10090  
745 3U0T 1 A, C ponezumab LC Fab 9606  
746 1C12 1 A PROTEIN (ANTIBODY FRAGMENT FAB) 10090  
747 1KB5 3 L ANTIBODY DESIRE-1 CLEAVED BY PAPAIN FAB 10090  
748 3ZDZ 4 F, L 10E5 FAB LIGHT CHAIN 10090  
749 2VDN 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
750 1MF2 1 L, M MONOCLONAL ANTIBODY F11.2.32 FAB FRAGMENT 10090  
751 3FO0 1 L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090  
752 1TQB 3 C VRQ14 Fab light chain VRQ14 Fab fragment 10090  
753 4LCU 2 B Fab heavy chain 10090  
754 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606  
755 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606  
756 1LO4 1 L If kappa light chain Fab fragment 10090  
757 1IGF 1 L, M IGG1-KAPPA B13I2 FAB (LIGHT CHAIN) 10090  
758 1WCB 1 A, L FAB FRAGMENT OF CATALYTIC ANTIBODY 15A9, LIGHT CHAIN 10090  
759 2VDM 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
760 4ENE 3 D, F light chain of Fab fragment 10090  
761 2BDN 2 L Antibody light chain 11K2 fab fragment 10090  
762 2F19 1 L IGG2B-KAPPA R19.9 FAB (LIGHT CHAIN) 10090  
763 2NYY 2 C CR1 monoclonal antibody light chain 9606  
764 3CLE 1 L Fab light chain 10090  
765 2GCY 1 A huC25 fab fragment light chain 10090  
766 4OCY 2 L Fab ADD058 Light Chain 10090  
767 4JLR 2 B, L Motavizumab Fab light chain 9606  
768 2QQK 3 L Antibody Light Chain 9606  
769 4J1U 1 A, C, E antibody 93F3 Light chain 10090  
770 2PW2 1 A 2F5 Fab' heavy chain 9606  
771 1ZTX 3 L Light Chain of E16 Antibody VL and CL Domains 10090  
772 3NGB 3 C, F, K, L Antigen binding fragment of light chain: Antibody VRC01 9606  
773 3IJS 1 A, C Immunoglobulin light chain (IGG3) 10090  
774 1I9I 1 L RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB FRAGMENT LIGHT CHAIN 10090  
775 2J88 3 L FAB 10090  
776 2GK0 1 A, L Catalytic elimination antibody 13G5 light chain Fab fragment 10090  
777 2F58 1 L PROTEIN (IGG1 FAB 58.2 ANTIBODY (LIGHT CHAIN)) FAB FRAGMENT 10090  
778 1H3P 2 L ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
779 4CAD 1 A, D, G, J ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
780 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090  
781 2PW1 1 A 2F5 Fab fragment heavy chain 9606  
782 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606  
783 3OR7 2 B antibody fab fragment light chain 10090  
784 1TPX 3 C the VRQ14 Fab residues (1-214) 10090  
785 4KXZ 3 I, L, M, P GC1008 Light Chain 9606  
786 3I02 1 A, C Immunoglobulin light chain S54-10 Fab light chain 10090  
787 3BT2 3 L anti-uPAR antibody, light chain Fab fragment, light chain 10090  
788 2R2E 1 A Fab, antibody fragment (IgG1k), light chain 10090  
789 1TZH 2 A, L Fab YADS1 Light Chain 10090  
790 4JZJ 3 B, L Fab Light Chain 10090  
791 1RMF 1 L IGG2A-KAPPA R6.5 FAB (LIGHT CHAIN) 10090  
792 1GGI 1 L, M IGG2A 50.1 FAB (LIGHT CHAIN) 10090  
793 1MNU 1 L PROTEIN (IGG2A-KAPPA ANTIBODY MN12H2 (LIGHT CHAIN)) FAB FRAGMENT 10090  
794 1JHK 1 L Ig kappa-chain 10090  
795 4M6O 1 L CNTO7309 light chain 9606  
796 4IJ3 2 B Light chain of FAB fragment 10090  
797 3QEH 2 B, D, F, H Fab fragment of human anti-HIV-1 Env antibody N12-i15,light chain Fab light chain 9606  
798 4OLW 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
799 3RPI 1 B, L Light chain from highly potent anti-HIV neutralizing antibody 9606  
800 1FRG 1 L IGG2A 26/9 FAB (LIGHT CHAIN) 10090  
801 1GGC 1 L IGG2A-KAPPA 50.1 FAB (LIGHT CHAIN) 10090  
802 1BBD 1 L IGG2A-KAPPA 8F5 FAB (LIGHT CHAIN) 10090  
803 1T4K 1 A, C IMMUNOGLOBULIN IGG1, KAPPA LIGHT CHAIN antibody FAB 93f3 10090  
804 3G5Z 1 A 175 light chain 10090  
805 4DVR 2 L Fab 48d Light chain 9606  
806 3EYQ 1 C M2J5 Fab 9606  
807 1CGS 1 L IGG2B-KAPPA NC6.8 FAB (LIGHT CHAIN) 10090  
808 1V7M 1 L, M Monoclonal TN1 Fab Light Chain Fab Light Chain 10090  
809 1ND0 1 A, C, E, G IMMUNOGLOBULIN IGG2A IMMUNOGLOBULIN FAB FRAGMENT, light chain 10090  
810 3WFB 1 L antibody fab fragment light chain 10090  
811 2O5Y 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
812 2Z91 2 B, D Anti-ciguatoxin antibody 10C9 FAB light chain 10090  
813 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606  
814 2AAB 1 L anti-idiotypic monoclonal antibody (light chain) 10090  
815 4F37 3 K, L Fab WO2 anti-amyloid-beta antibody Fab fragment 10090  
816 3QG7 2 L AP4-24H11 Antibody Light Chain 10090  
817 3PHO 1 A S64-4 Fab (IgG1) light chain 10090  
818 3CFK 1 A, C, E, G, J, L, M, O CATALYTIC ANTIBODY FAB 34E4 LIGHT CHAIN FUSION PROTEIN OF THE VARIABLE DOMAIN (AUTHOR RESIDUES 1-105) AND THE CONSTANT DOMAIN (UNP RESIDUES 131-239) 10090  
819 3VG9 2 B antibody fab fragment light chain 10090  
820 2GJZ 1 A, L Catalytic elimination antibody 13G5 light chain Fab fragment 10090  
821 1A5F 1 L MONOCLONAL ANTI-E-SELECTIN 7A9 ANTIBODY (LIGHT CHAIN) FAB FRAGMENT 10090  
822 1NSN 1 L IGG FAB (IGG1, KAPPA) 10090  
823 2OJZ 1 L, M Fab ED10 light chain 10090  
824 2ATK 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
825 1CLY 1 L IGG FAB (HUMAN IGG1, KAPPA) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER CHIMERIC FRAGMENT (BR96) 9606  
826 4GW4 1 B, L 3BNC60 Fab Light-chain 9606  
827 2NLJ 1 A antibody Fab fragment light chain 10090  
828 1YYL 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
829 1U8L 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
830 2OZ4 2 L FAB FRAGMENT LIGHT CHAIN 10090  
831 1IBG 1 L IGG2B-KAPPA 40-50 FAB (LIGHT CHAIN) 10090  
832 2NY6 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
833 1EO8 3 L ANTIBODY (LIGHT CHAIN) FAB FRAGMENT OF ANTIBODY BH151 10090  
834 4KPH 1 L, M N62 light chain 10090  
835 3DVG 1 A Human IgG1 fab fragment light chain 9606  
836 4I9W 2 D, F ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
837 1KCR 1 L PC283 IMMUNOGLOBULIN light chain 10090  
838 1GHF 1 L ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT 10090  
839 1DBB 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
840 1CLZ 1 L IGG FAB (IGG3, KAPPA) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER FRAGMENT (MBR96) 10090  
841 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606  
842 2AGJ 1 L Yvo Fab, Light Chain 9606  
843 1N64 1 L Fab 19D9D6 light chain 10090  
844 3I2C 1 L CNTO4088 LIGHT CHAIN 10090  
845 4JKP 3 L Light chain of antibody 45-46M2 9606  
846 1FN4 1 A, C MONOCLONAL ANTIBODY AGAINST ACETYLCHOLINE RECEPTOR 10116  
847 1QFU 3 L PROTEIN (IMMUNOGLOBULIN IGG1-KAPPA ANTIBODY (LIGHT CHAIN)) FAB FRAGMENT 10090  
848 3EYO 1 A, C 8f9 Fab 9606  
849 2G2R 1 A, L Green-fluorescent antibody (11G10)-light chain 10090  
850 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606  
851 3Q3G 1 A, C, F, J Antibody Light Chain 10090  
852 3ZE1 4 F, L 10E5 FAB LIGHT CHAIN 10090  
853 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606  
854 3B2U 1 D, G, K, L, O, R, U, X IMC-11F8 Fab Light chain 9606  
855 4DN4 1 L CNTO888 LIGHT CHAIN 9606  
856 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606  
857 4DGI 3 L POM1 Fab Light chain 10090  
858 3F58 1 L PROTEIN (IMMUNOGLOBULIN GAMMA I (58.2)) LIGHT CHAIN OF FAB 10090  
859 1GGB 1 L IGG2A-KAPPA 50.1 FAB (LIGHT CHAIN) 10090  
860 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090  
861 2FJG 2 A, L Fab light chain 9606  
862 1DBJ 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
863 1YMH 1 A, C Fab 16D9D6, light chain 10090  
864 4DKF 3 L, M FAb2 Light Chain 9606  
865 1UWE 2 L, U, X ANTIBODY 14D9 FAB LIGHT CHAIN, RESIDUES 1-212 10090  
866 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606  
867 4FAB 1 L IGG2A-KAPPA 4-4-20 FAB (LIGHT CHAIN) 10090  
868 1IT9 1 L HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN FAB FRAGMENT 10090  
869 1DBA 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
870 2DWE 2 B ANTIBODY FAB LIGHT CHAIN 10090  
871 4GAJ 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090  
872 3EFD 1 L FabL 10090  
873 4JR9 3 L Immunoglobulin Kappa, Light chain 10090  
874 4LF3 1 A, D Fab heavy chain 10090  
875 3STZ 2 B antibody Fab fragment light chain 10090  
876 2A6I 1 A Germline antibody 36-65 Fab light chain Fab 10090  
877 3ZE0 4 F, L 10E5 FAB LIGHT CHAIN 10090  
878 1PSK 1 L ANTIBODY FAB 10090  
879 3VW3 1 L Anti-(6-4) photoproduct antibody 64M-5 Fab (light chain) 10090  
880 3GI9 1 L 7F11 Anti-ApcT Monoclonal Fab Light Chain 10090  
881 1DBM 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
882 3RA7 1 L, M Fab fragment, light chain 10090  
883 1B4J 1 L ANTIBODY V DOMAIN AND C DOMAIN 9606  
884 1UWG 2 L, X ANTIBODY 14D9 CATALYTIC ANTIBODY 19C9 FAB LIGHT CHAIN, RESIDUES 1-213 10090  
885 4JPV 3 L LIGHT CHAIN OF ANTIBODY 3BNC117 9606  
886 1CL7 1 L PROTEIN (IGG1 ANTIBODY 1696 (light chain)) FAB 10090  
887 1BAF 1 L IGG1-KAPPA AN02 FAB (LIGHT CHAIN) 10090  
888 4LEO 2 B RG7116 Fab light chain 10090  
889 4G7Y 2 L Fragment antibody light chain 9606  
890 1BLN 1 A, C PROTEIN (MONOCLONAL ANTIBODY MRK-16 (LIGHT CHAIN)) FAB 10090  
891 1IGT 1 A, C IGG2A INTACT ANTIBODY - MAB231 10090  
892 4PY8 4 J antibody 3.1 light chain Fab 9606  
893 3SDY 4 L Antibody CR8020, Light Chain 9606  
894 3DVN 1 A, L Human IgG1 fab fragment light chain 9606  
895 3IXT 1 B, L Motavizumab Fab light chain 10090  
896 2P8M 1 A nmAb 2F5, light chain 9606  
897 4I3R 3 L Light chain of VRC-PG04 Fab 9606  
898 4NP4 3 L, M bezlotoxumab light chain 9606  
899 2ADI 1 A Q425 Fab Light chain 10090  
900 1FJ1 1 A, C HYBRIDOMA ANTIBODY LA2 (LIGHT CHAIN) FAB FRAGMENT 10090  
901 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598  
902 2ZCH 2 L monoclonal antibody 8G8F5 Fab 10090  
903 1FH5 1 L MONOCLONAL ANTIBODY MAK33 FAB LIGHT CHAIN 9606  
904 1NLD 1 L FAB1583 10090  
905 4M7Z 2 C, L S25-26 Fab (Igg1k) Light Chain 10090  
906 3IKC 1 A, C Immunoglobulin light chain (IGG3) 10090  
907 1BBJ 1 A, L IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) 10090  
908 3BKY 2 L the Fab fragment of chimeric 2H7, light chain 10090  
909 4ERS 1 L Fab light chain 9606  
910 2OSL 1 B, L light chain of the Rituximab Fab fragment The protein was produced as a chimeric fab fragment. residues 1-106 is from murine and 107-213 is from human. 10090  
911 3O45 1 B, L Mouse monoclonal antibody 101F 101F Fab light chain 10090  
912 1HQ4 1 A, C ANTIBODY HA5-19A4 FAB LIGHT CHAIN VARIABLE REGIONS OF FAB LIGHT AND HEAVY CHAINS 10090  
913 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606  
914 1MCP 1 L IGA-KAPPA MCPC603 FAB (LIGHT CHAIN) 10090  
915 4HC1 3 L, N 10G3 light chain 10090  
916 1HIM 1 H, J IGG2A-KAPPA 17/9 FAB (HEAVY CHAIN) 10090  
917 4MWF 2 B, L Fab AR3C light chain 9606  
918 3OR6 2 B antibody fab fragment light chain 10090  
919 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606  
920 3SQO 3 L J16 Light chain 9606  
921 4FFV 2 C, L 11A19 Fab light chain 10090  
922 4K3J 4 L Onartuzumab Fab light chain 10090  
923 1ZWI 2 B monoclonal antibody light chain 10090  
924 2DWD 2 B ANTIBODY FAB LIGHT CHAIN 10090  
925 2VC2 4 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
926 1FBI 1 L, P IGG1 F9.13.7 FAB (LIGHT CHAIN) 10090  
927 4C83 2 B, D LPT3 LIGHT CHAIN 10090  
928 4PS4 1 L M1295 LIGHT CHAIN 9606  
929 2A6J 1 A, L Germline antibody 36-65 Fab light chain Fab 10090  
930 1F11 1 A, C F124 IMMUNOGLOBULIN (KAPPA LIGHT CHAIN) FAB FRAGMENT 10090  
931 1Y18 1 A, C, E, L Catalytic antibody 34E4 light chain The variable domain (residues 1-107) is from a murine source and the constant domain (108-214) is from a human source 10090  
932 1YY9 2 C Cetuximab Fab Light chain 10090  
933 2HVJ 2 B antibody Fab light chain 10090  
934 4AG4 3 L MONOCLONAL ANTIBODY 3E3 LIGHT CHAIN MONOCLONAL ANTIBODY AGAINST HUMAN DDR1 10090  
935 3NZ8 2 B, L Mouse anti V3 antibody 7C8 Fab, light chain Fab 10090  
936 1HZH 2 L, M IMMUNOGLOBULIN LIGHT CHAIN 9606  
937 3HI1 2 A, L F105 Light Chain 9606  
938 4PY7 2 B, J antibody 3.1 light chain Fab 9606  
939 2BOB 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
940 4K8R 3 C Fab1, light chain 9606  
941 1RZK 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606  
942 2DBL 1 L IGG1-KAPPA DB3 FAB (LIGHT CHAIN) 10090  
943 1ZLU 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
944 1BOG 1 A ANTIBODY (CB 4-1) FAB DERIVED FROM IGG2A KAPPA FAB FRAGMENT 10090  
945 1G9N 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
946 3QA3 1 A, C, F, J Antibody Light chain 10090  
947 2MCP 1 L IGA-KAPPA MCPC603 FAB (LIGHT CHAIN) 10090  
948 4KK8 3 D, F Fab, light chain 10090  
949 1TZI 1 A Fab YADS2 Light Chain 10090  
950 3LD8 2 B antibody Fab fragment light chain 10032  
951 1QLR 1 A, C IGM KAPPA CHAIN V-III (KAU COLD AGGLUTININ) FAB FRAGMENT 9606  
952 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090  
953 1EGJ 2 L ANTIBODY (LIGHT CHAIN) 10090  
954 1AI1 1 L IGG1-KAPPA 59.1 FAB (LIGHT CHAIN) 10090  
955 2IGF 1 L IGG1-KAPPA B13I2 FAB (LIGHT CHAIN) 10090  
956 4KRP 3 C Cetuximab light chain Fab 10090  
957 1CFQ 1 A PROTEIN (IGG2A KAPPA ANTIBODY CB41 (LIGHT CHAIN)) FAB 10090  
958 1XGY 1 L, M K42-41L Fab Light Chain Anitgen Binding Fragment, Fab 10090  
959 4JPW 3 L LIGHT CHAIN OF ANTIBODY 12A21 9606  
960 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606  
961 1TQC 3 C VRQ14 Fab light chain VRQ14 Fab fragment 10090  
962 1MHP 3 L, Y FAB FRAGMENT, light chain 10090  
963 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544  
964 4JB9 3 L antibody VRC06 light chain 9606  
965 2W9E 3 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090  
966 1IAI 1 L IDIOTYPIC FAB 730.1.4 (IGG1) OF VIRUS NEUTRALIZING ANTIBODY 10090  
967 1IAI 3 M ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) 10090  
968 3VI3 3 E, L SG/19 Fab fragment (Light chain) 10090  
969 1OTS 3 D, F Fab fragment (light chain) 10090  
970 3U9P 3 L, M Monoclonal Fab Fragment Light Chain 10116  
971 3O11 1 A, L C706 LIGHT CHAIN variable region, Ig kappa chain C region chimera 10090  
972 1M71 1 A light chain of the monoclonal antibody Fab SYA/J6 10090  
973 1FL6 1 A, L ANTIBODY GERMLINE PRECURSOR TO 28B4 LIGHT CHAIN (CHAINS L AND A) 10090  
974 3CK0 1 L PROTEIN (IMMUNOGLOBULIN; LIGHT CHAIN) IGG1, KAPPA FAB FRAGMENT 10090  
975 4RDQ 2 F, H, J, L, N Fab antibody fragment, light chain 10090  
976 1XCT 2 A, C Monoclonal antibody 19D9D6 Light chain 10090  
977 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606  
978 2QQL 3 L Antibody Light Chain 9606  
979 3B9K 1 C, L Fab Heavy Chain Fab Fragment 10117  
980 2P8P 1 A nmAb 2F5, light chain 9606  
981 4AM0 2 B, D, F, L FAB 2H12, LIGHT CHAIN 10090  
982 2ADJ 1 A Q425 Fab Light chain 10090  
983 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606  
984 1CFS 1 A PROTEIN (IGG2A KAPPA ANTIBODY CB41 (LIGHT CHAIN)) FAB 10090  
985 4JRE 3 C, L Immunoglobulin Kappa, Light chain 10090  
986 3WD5 2 L Adalimumab Light Chain 9606  
987 2GSI 1 A, C, E, G Immunoglobulin (kappa) light chain 10090  
988 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606  
989 4GMS 3 L, M, N Fab S139/1 light chain 10090  
990 4GAY 2 B, L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN Fab fragment of AP33 light chain 10090  
991 2J5L 2 B FAB FRAGMENT OF MONOCLONAL ANTIBODY F8.12.19 MONOCLONAL ANTIBODY ISOTYPE IS IGG1, KAPPA ANTIGEN-BINDING FRAGMENT FAB, LIGHT CHAIN 10090  
992 3GI8 2 L 7F11 Anti-ApcT Monoclonal Fab Light Chain 10090  
993 3OPZ 3 L, M, N light chain of the Fab fragment of immunoglobulin G 10090  
994 2ITD 2 B antibody Fab fragment light chain 10090  
995 1V7N 1 L, M, N, O Monoclonal TN1 Fab Light Chain Fab Light Chain 10090  
996 2HH0 1 L Light Chain, P-Clone Fab, Chimera 2-109 (mouse), 110-271 (human) 10090  
997 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606  
998 3U46 2 B, L CH02 Light chain Fab 9606  
999 3IU3 2 B, D, L Light chain of Fab fragment of Basiliximab 10090  
1000 1JNL 1 L monoclonal anti-estradiol 17E12E5 immunoglobulin kappa chain 10090  
 
Sequence Clusters for the Sequence Entities in PDB 3TCL
Entity #1: Chains: A,H - CH04 Heavy Chain Fab protein, length: 237 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 1 3 11171
95% 1 3 10766
90% 1 3 10606
70% 248 1490 2
50% 505 3090 1
40% 505 3091 1
30% 548 3653 1
Entity #2: Chains: B,L - CH04 Light Chain Fab protein, length: 215 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 1 1 30523
95% 1 1 23502
90% 54 368 4
70% 207 1297 3
50% 506 3090 1
40% 506 3091 1
30% 549 3653 1
 

Documentation

Click here for more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB.